Human cell-based artificial antigen-presenting cells for cancer immunotherapy
Published 2013 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Human cell-based artificial antigen-presenting cells for cancer immunotherapy
Authors
Keywords
-
Journal
IMMUNOLOGICAL REVIEWS
Volume 257, Issue 1, Pages 191-209
Publisher
Wiley
Online
2013-12-13
DOI
10.1111/imr.12129
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Cutting Edge: CD4+ T Cell-Derived IL-2 Is Essential for Help-Dependent Primary CD8+ T Cell Responses
- (2014) E. B. Wilson et al. JOURNAL OF IMMUNOLOGY
- Growth and Activation of Natural Killer Cells Ex Vivo from Children with Neuroblastoma for Adoptive Cell Therapy
- (2013) Y. Liu et al. CLINICAL CANCER RESEARCH
- Natural Killer T cell obsession with self-antigens
- (2013) Laurent Gapin et al. CURRENT OPINION IN IMMUNOLOGY
- T cell anergy, exhaustion, senescence, and stemness in the tumor microenvironment
- (2013) Joel Crespo et al. CURRENT OPINION IN IMMUNOLOGY
- Interleukin-2 at the Crossroads of Effector Responses, Tolerance, and Immunotherapy
- (2013) Wei Liao et al. IMMUNITY
- IL-21 promotes the expansion of CD27+CD28+ tumor infiltrating lymphocytes with high cytotoxic potential and low collateral expansion of regulatory T cells
- (2013) Saskia JAM Santegoets et al. Journal of Translational Medicine
- Treating B-cell cancer with T cells expressing anti-CD19 chimeric antigen receptors
- (2013) James N. Kochenderfer et al. Nature Reviews Clinical Oncology
- Chimeric Antigen Receptor–Modified T Cells for Acute Lymphoid Leukemia
- (2013) Stephan A. Grupp et al. NEW ENGLAND JOURNAL OF MEDICINE
- Manufacture of Clinical-Grade CD19-Specific T Cells Stably Expressing Chimeric Antigen Receptor Using Sleeping Beauty System and Artificial Antigen Presenting Cells
- (2013) Harjeet Singh et al. PLoS One
- CD19-Targeted T Cells Rapidly Induce Molecular Remissions in Adults with Chemotherapy-Refractory Acute Lymphoblastic Leukemia
- (2013) R. J. Brentjens et al. Science Translational Medicine
- The Basic Principles of Chimeric Antigen Receptor Design
- (2013) Michel Sadelain et al. Cancer Discovery
- Decisions About Dendritic Cells: Past, Present, and Future
- (2012) Ralph M. Steinman Annual Review of Immunology
- Harnessing the Power of the Immune System to Target Cancer
- (2012) Gregory Lizée et al. Annual Review of Medicine
- A foundation for universal T-cell based immunotherapy: T cells engineered to express a CD19-specific chimeric-antigen-receptor and eliminate expression of endogenous TCR
- (2012) H. Torikai et al. BLOOD
- Large-scale ex vivo expansion and characterization of natural killer cells for clinical applications
- (2012) Natalia Lapteva et al. CYTOTHERAPY
- Structural insights into the common γ-chain family of cytokines and receptors from the interleukin-7 pathway
- (2012) Scott T. R. Walsh IMMUNOLOGICAL REVIEWS
- HLA-DM: arbiter conformationis
- (2012) Andrea Ferrante IMMUNOLOGY
- The immunosuppressive tumour network: myeloid-derived suppressor cells, regulatory T cells and natural killer T cells
- (2012) Dennis Lindau et al. IMMUNOLOGY
- Sorting Through Subsets
- (2012) Christopher A. Klebanoff et al. JOURNAL OF IMMUNOTHERAPY
- Therapeutic Cancer Vaccines: Current Status and Moving Forward
- (2012) J. Schlom JNCI-Journal of the National Cancer Institute
- Cancer immunotherapy
- (2012) Thomas F. Gajewski Molecular Oncology
- From IL-2 to IL-37: the expanding spectrum of anti-inflammatory cytokines
- (2012) Jacques Banchereau et al. NATURE IMMUNOLOGY
- Identification, isolation and in vitro expansion of human and nonhuman primate T stem cell memory cells
- (2012) Enrico Lugli et al. Nature Protocols
- Ex Vivo Expansion of Human CD8+ T Cells Using Autologous CD4+ T Cell Help
- (2012) Marcus O. Butler et al. PLoS One
- Membrane-Bound IL-21 Promotes Sustained Ex Vivo Proliferation of Human Natural Killer Cells
- (2012) Cecele J. Denman et al. PLoS One
- IL-7 signaling and CD127 receptor regulation in the control of T cell homeostasis
- (2012) Florent Carrette et al. SEMINARS IN IMMUNOLOGY
- Targeting the MHC Class II antigen presentation pathway in cancer immunotherapy
- (2012) Jacques Thibodeau et al. OncoImmunology
- B-cell depletion and remissions of malignancy along with cytokine-associated toxicity in a clinical trial of anti-CD19 chimeric-antigen-receptor-transduced T cells
- (2011) J. N. Kochenderfer et al. BLOOD
- In vitro generated anti-tumor T lymphocytes exhibit distinct subsets mimicking in vivo antigen-experienced cells
- (2011) Shicheng Yang et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- Reprogramming CD19-Specific T Cells with IL-21 Signaling Can Improve Adoptive Immunotherapy of B-Lineage Malignancies
- (2011) H. Singh et al. CANCER RESEARCH
- Induction of HLA-DP4–Restricted Anti-Survivin Th1 and Th2 Responses Using an Artificial Antigen-Presenting Cell
- (2011) Makito Tanaka et al. CLINICAL CANCER RESEARCH
- Genetically retargeting CD8+ lymphocyte subsets for cancer immunotherapy
- (2011) Cameron J Turtle et al. CURRENT OPINION IN IMMUNOLOGY
- The mechanism of HLA-DM induced peptide exchange in the MHC class II antigen presentation pathway
- (2011) Monika-Sarah ED Schulze et al. CURRENT OPINION IN IMMUNOLOGY
- Infusing CD19-Directed T Cells to Augment Disease Control in Patients Undergoing Autologous Hematopoietic Stem-Cell Transplantation for Advanced B-Lymphoid Malignancies
- (2011) Partow Kebriaei et al. HUMAN GENE THERAPY
- CD8+ T Cells: Foot Soldiers of the Immune System
- (2011) Nu Zhang et al. IMMUNITY
- Cancer Immunotherapy Comes of Age
- (2011) Suzanne L. Topalian et al. JOURNAL OF CLINICAL ONCOLOGY
- Engineered artificial antigen presenting cells facilitate direct and efficient expansion of tumor infiltrating lymphocytes
- (2011) Qunrui Ye et al. Journal of Translational Medicine
- CARs on Track in the Clinic
- (2011) Donald B Kohn et al. MOLECULAR THERAPY
- Cancer immunotherapy comes of age
- (2011) Ira Mellman et al. NATURE
- Normal T cell homeostasis: the conversion of naive cells into memory-phenotype cells
- (2011) Jonathan Sprent et al. NATURE IMMUNOLOGY
- Cancer immunotherapy – revisited
- (2011) W. Joost Lesterhuis et al. NATURE REVIEWS DRUG DISCOVERY
- Chimeric Antigen Receptor–Modified T Cells in Chronic Lymphoid Leukemia
- (2011) David L. Porter et al. NEW ENGLAND JOURNAL OF MEDICINE
- Massive ex Vivo Expansion of Human Natural Regulatory T Cells (Tregs) with Minimal Loss of in Vivo Functional Activity
- (2011) K. L. Hippen et al. Science Translational Medicine
- Establishment of Antitumor Memory in Humans Using in Vitro-Educated CD8+ T Cells
- (2011) M. O. Butler et al. Science Translational Medicine
- T Cells with Chimeric Antigen Receptors Have Potent Antitumor Effects and Can Establish Memory in Patients with Advanced Leukemia
- (2011) M. Kalos et al. Science Translational Medicine
- Engraftment of human central memory-derived effector CD8+ T cells in immunodeficient mice
- (2010) X. Wang et al. BLOOD
- Redirecting T-cell specificity by introducing a tumor-specific chimeric antigen receptor
- (2010) B. Jena et al. BLOOD
- Artificial Antigen-Presenting Cells for Use in Adoptive Immunotherapy
- (2010) Cameron J. Turtle et al. CANCER JOURNAL
- Adoptive T cell therapy of cancer
- (2010) Malcolm K Brenner et al. CURRENT OPINION IN IMMUNOLOGY
- IL-6: Regulator of Treg/Th17 balance
- (2010) Akihiro Kimura et al. EUROPEAN JOURNAL OF IMMUNOLOGY
- Naive tumor-specific CD4+T cells differentiated in vivo eradicate established melanoma
- (2010) Ying Xie et al. JOURNAL OF EXPERIMENTAL MEDICINE
- Tumor-reactive CD4+T cells develop cytotoxic activity and eradicate large established melanoma after transfer into lymphopenic hosts
- (2010) Sergio A. Quezada et al. JOURNAL OF EXPERIMENTAL MEDICINE
- Current Experience With CTLA4-blocking Monoclonal Antibodies for the Treatment of Solid Tumors
- (2010) Sanjiv S. Agarwala et al. JOURNAL OF IMMUNOTHERAPY
- Improved Survival with Ipilimumab in Patients with Metastatic Melanoma
- (2010) F. Stephen Hodi et al. NEW ENGLAND JOURNAL OF MEDICINE
- Expansion of Highly Cytotoxic Human Natural Killer Cells for Cancer Cell Therapy
- (2009) H. Fujisaki et al. CANCER RESEARCH
- Guidelines for the Evaluation of Immune Therapy Activity in Solid Tumors: Immune-Related Response Criteria
- (2009) J. D. Wolchok et al. CLINICAL CANCER RESEARCH
- MART-1–Specific Melanoma Tumor-Infiltrating Lymphocytes Maintaining CD28 Expression Have Improved Survival and Expansion Capability Following Antigenic Restimulation In Vitro
- (2009) Yufeng Li et al. JOURNAL OF IMMUNOLOGY
- Wnt signaling arrests effector T cell differentiation and generates CD8+ memory stem cells
- (2009) Luca Gattinoni et al. NATURE MEDICINE
- Adoptively transferred effector cells derived from naive rather than central memory CD8+ T cells mediate superior antitumor immunity
- (2009) C. S. Hinrichs et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- A Vital Role for Interleukin-21 in the Control of a Chronic Viral Infection
- (2009) J. S. Yi et al. SCIENCE
- IL-21 Is Required to Control Chronic Viral Infection
- (2009) H. Elsaesser et al. SCIENCE
- IL-21R on T Cells Is Critical for Sustained Functionality and Control of Chronic Viral Infection
- (2009) A. Frohlich et al. SCIENCE
- Stem cell-like plasticity of naïve and distinct memory CD8+ T cell subsets
- (2009) Christian Stemberger et al. SEMINARS IN IMMUNOLOGY
- IL-2 and IL-21 confer opposing differentiation programs to CD8+ T cells for adoptive immunotherapy
- (2008) C. S. Hinrichs et al. BLOOD
- Dissociation of Its Opposing Immunologic Effects Is Critical for the Optimization of Antitumor CD8+ T-Cell Responses Induced by Interleukin 21
- (2008) S. Ansen et al. CLINICAL CANCER RESEARCH
- Molecular Antagonism and Plasticity of Regulatory and Inflammatory T Cell Programs
- (2008) Xuexian O. Yang et al. IMMUNITY
- Multiple roles for CD4+T cells in anti-tumor immune responses
- (2008) Richard Kennedy et al. IMMUNOLOGICAL REVIEWS
- Adoptive transfer of effector CD8+ T cells derived from central memory cells establishes persistent T cell memory in primates
- (2008) Carolina Berger et al. JOURNAL OF CLINICAL INVESTIGATION
- Adoptive Cell Therapy for Patients With Metastatic Melanoma: Evaluation of Intensive Myeloablative Chemoradiation Preparative Regimens
- (2008) Mark E. Dudley et al. JOURNAL OF CLINICAL ONCOLOGY
- Virus-specific T cells engineered to coexpress tumor-specific receptors: persistence and antitumor activity in individuals with neuroblastoma
- (2008) Martin A Pule et al. NATURE MEDICINE
- Treatment of Metastatic Melanoma with Autologous CD4+ T Cells against NY-ESO-1
- (2008) Naomi N. Hunder et al. NEW ENGLAND JOURNAL OF MEDICINE
- Interleukin-21: Basic Biology and Implications for Cancer and Autoimmunity
- (2007) Rosanne Spolski et al. Annual Review of Immunology
- The Biology of Interleukin-2
- (2007) Thomas R. Malek Annual Review of Immunology
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now